Search for: "Companies A, B, and C"
Results 3981 - 4000
of 12,892
Sorted by Relevance
|
Sort by Date
10 May 2011, 3:24 pm
(A) the adulteration originated with the responsible party; (B) the responsible party detected the adulteration prior to any transfer to another person of such article of food; and (C) the responsible party – (i) corrected such adulteration; or (ii) destroyed or caused the destruction of such article of food. [read post]
23 Mar 2010, 3:45 pm
Many nanotech companies are small and precariously funded; a two year prohibition on manufacture or import could very well drive them into bankruptcy, depriving Canadians of the benefits of nanotechnology mentioned in Mr. [read post]
14 Sep 2009, 2:49 am
(a) In General- Section 103(b) of the Employee Retirement Income Security Act of 1974 (29 U.S.C. 1023(b)) is amended– (1) in paragraph (3)(C), by striking `value;’ and inserting `value, including, in the case of a defined benefit pension plan, a separate schedule identifying each hedge fund (as defined in paragraph 5) in which amounts held for investment under the plan are invested as of the end of the plan year covered by the annual report and the… [read post]
8 Dec 2016, 3:20 am
G5/83 b. [read post]
23 Nov 2022, 4:00 am
Villaggi c. [read post]
14 Sep 2022, 12:05 pm
b. [read post]
27 Mar 2013, 9:52 am
Here is an example from the Guidelines of what not to do by simply adding a hyper link labeled “Important Health Information”: That said, if the details of the disclosure are too difficult to place on the same screen as the claim, and a hyperlink is necessary, then the hyperlink should (a) be obvious and labeled to ensure that the consumer understands its relevance and importance; (b) be used consistently with consumer use of hyperlinks, (c) be placed as close as… [read post]
16 Dec 2013, 10:22 am
” In addressing the board's capacity to sue and be sued, Judge Wigenton stated that pursuant to Federal Rule of Civil Procedure 17(b)(2), the “[c]apacity to sue or be sued ... for a corporation, [is determined] by the law under which it was organized. [read post]
28 Jan 2009, 9:40 am
Dodd; Professor John C. [read post]
15 Mar 2018, 5:30 am
Kaspersky products put Russian intelligence services squarely inside the security boundary of any company that uses them. [read post]
18 Jan 2022, 5:53 am
”Better Markets’ four suggestions asked the Commission to consider: (a) requiring reporting on the use of collateral; (b) reevaluating the proposal’s timing deadlines; (c) closing any potential loophole that would permit evasion by characterizing securities lending transactions as repurchase agreements; and (d) deem the proposals merely a first step in addressing short-selling issues.Better Markets considers securities lenders reporting their collateral use in… [read post]
13 Feb 2019, 9:43 am
See B. [read post]
14 Feb 2013, 8:08 pm
§1962(c) of the RICO Act, the court ruled. [read post]
1 Jul 2013, 8:39 am
Code § 35-43-5-2(b))• COUNT IX (Counterfeiting Under Ind. [read post]
24 May 2019, 4:00 am
New York State's Education Law §8405[3][f] requires that an applicant for a New York State psychoanalyst license must "[b]e of good moral character. [read post]
9 Oct 2014, 1:37 pm
These are that the beneficiary: A) is or at any time was a U.S. citizen or resident (within the meaning of section 7701(b)(1)(A)) while a beneficiary of the plan; B) has satisfied any requirement for filing a U.S. [read post]
24 May 2019, 4:00 am
New York State's Education Law §8405[3][f] requires that an applicant for a New York State psychoanalyst license must "[b]e of good moral character. [read post]
1 Jul 2013, 12:31 pm
§§ 1114, 1116, 1117, 1125(a) and (c); trademark infringement and unfair competition under the common law of the State of Indiana; and forgery under Indiana Code § 35- 43-5-2(b) as well as counterfeiting under Indiana Code § 35-43-5-2(a), pursuant to Indiana Code § 34-24-3-1. [read post]
22 Jul 2015, 12:40 pm
It is indicated, in combination with cisplatin, (a) for the treatment of patients with malignant pleural mesothelioma, or (b) for the initial treatment of locally advanced or metastatic nonsquamous non-small cell lung cancer. [read post]
